KIT2014 is a novel inhaled peptide therapy being developed for respiratory diseases including chronic obstructive pulmonary disease (COPD), non-CF bronch...
– KO-7246 regenerated functional β-cell mass and produced durable glycemic control in Type 1 and Type 2 diabetes models – – KO-7246...
Strategic investments strengthen resilience and service capabilities for innovative injectable therapies First of ten additional commercial ma...
Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, announced an agreement with ...
Tandem Diabetes Care, Inc. (NASDAQ: TNDM), a leading insulin delivery and diabetes technology company, announced that Tandem Mobi, the world’s smalle...
QIAGEN N.V. (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced that U.S. laboratories now have access to the complete QIAstat-Dx bloodstream infection p...
Sun Nuclear, a Mirion Medical company, announced that its AdaptCHECK™ software has been validated in collaboration with Siemens Healthineers technica...
Grünenthal, a global leader in pain management and research, and DKSH Business Unit Healthcare, a strategic healthcare business partner and leading pr...
Accuray Incorporated (NASDAQ: ARAY) announced that it had entered into agreements with Samsung HME America, Inc., dba NeuroLogica Corp. ("Samsung NeuroLogi...
Astellas Pharma Inc.announced that the first patient has been dosed in a Phase 3 study evaluating setidegrasib, a novel, investigational KRAS G12D-t...
Kadans Science Partner is pleased to welcome ACROBiosystems to The HIVE Innovation Center, its laboratory and office building dedicated to the life scien...
InnoCare Pharma, a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced that the Company has entered ...
Lōkahi Therapeutics, a subsidiary of Glucotrack, Inc., announced that The University of Alabama’s Culverhouse College of Business will continue it...
Cue Biopharma, a clinical-stage biopharmaceutical company targeting transformative therapies for immune-mediated diseases, announced positive topli...
© 2026 Biopharma Boardroom. All Rights Reserved.
